Formulary Drug List Changes
B3, M1, and M2 Formulary drug lists
Effective April 1, 2025
B3 formulary drug list
| Drug name | Description of change | Generic or more cost-effective option |
|---|---|---|
| ANALPRAM HC 2.5%-1% CREAM | Moving to Tier 3 | hydrocortisone/pramoxine 2.5-1% cream |
| SPRYCEL TABLETS | Moving to Tier 3 | dasatinib tablets |
M1 and M2 formulary drug lists
| Drug name | Description of change | Generic or more cost-effective option |
|---|---|---|
| isotretinoin capsules (select NDCs) | No longer covered | Accutane, Amnesteem, Claravis, Zenatane |
| MIPLYFFA CAPSULES | No longer covered | AQNEURSA PACKETS |
| PONVORY TABLETS | No longer covered | fingolimod capsules, dimethyl fumarate capsules |
| SPRYCEL TABLETS | No longer covered | dasatinib tablets |
M4 formulary drug list
| Drug name | Description of change | Generic or more cost-effective option |
|---|---|---|
| isotretinoin capsules (select NDCs) | No longer covered | Accutane, Amnesteem, Claravis, Zenatane |
| MIPLYFFA CAPSULES | No longer covered | AQNEURSA PACKETS |
| PONVORY TABLETS | No longer covered | fingolimod capsules, dimethyl fumarate capsules |
| SPRYCEL TABLETS | No longer covered | dasatinib tablets |
Effective March 1, 2025
No changes
Effective February 1, 2025
No changes
Effective April 1, 2025
B3 formulary drug list (no changes for A1/A2 list)
| Drug name | Description of change | Generic or more cost-effective option |
|---|---|---|
| ANALPRAM-HC 2.5 %-1 % CREAM | Moving to Tier 3 | hydrocortisone-pramoxine 2.5%-1% cream |
| SPRYCEL TABLETS | Moving to Tier 3 | dasatinib tablets |
B4 formulary drug list
| Drug name | Description of change | Generic or more cost-effective option |
|---|---|---|
| ANALPRAM HC 2.5%-1% CREAM | Moving to Tier 3 | hydrocortisone/pramoxine 2.5-1% cream |
Effective March 1, 2025
No changes
Effective February 1, 2025
No changes
*These drugs have been selected by an independent group of experts made up of doctors and pharmacists. This group reviews drugs to see how well they work relative to their cost. They also compare their effectiveness to similar drugs used to treat the same condition. Please talk with your doctor to see if these new options are right for you.